155 related articles for article (PubMed ID: 38563782)
1. An evolution of Nanopore next-generation sequencing technology: implications for medical microbiology and public health.
Mostafa HH
J Clin Microbiol; 2024 May; 62(5):e0024624. PubMed ID: 38563782
[TBL] [Abstract][Full Text] [Related]
2. Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
Bogaerts B; Van den Bossche A; Verhaegen B; Delbrassinne L; Mattheus W; Nouws S; Godfroid M; Hoffman S; Roosens NHC; De Keersmaecker SCJ; Vanneste K
J Clin Microbiol; 2024 May; 62(5):e0157623. PubMed ID: 38441926
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the accuracy of bacterial genome reconstruction with Oxford Nanopore R10.4.1 long-read-only sequencing.
Sanderson ND; Hopkins KMV; Colpus M; Parker M; Lipworth S; Crook D; Stoesser N
Microb Genom; 2024 May; 10(5):. PubMed ID: 38713194
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Illumina versus Nanopore 16S rRNA Gene Sequencing of the Human Nasal Microbiota.
Heikema AP; Horst-Kreft D; Boers SA; Jansen R; Hiltemann SD; de Koning W; Kraaij R; de Ridder MAJ; van Houten CB; Bont LJ; Stubbs AP; Hays JP
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967250
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Illumina and Oxford Nanopore Technology for genome analysis of Francisella tularensis, Bacillus anthracis, and Brucella suis.
Linde J; Brangsch H; Hölzer M; Thomas C; Elschner MC; Melzer F; Tomaso H
BMC Genomics; 2023 May; 24(1):258. PubMed ID: 37173617
[TBL] [Abstract][Full Text] [Related]
6. Recovery of small plasmid sequences via Oxford Nanopore sequencing.
Wick RR; Judd LM; Wyres KL; Holt KE
Microb Genom; 2021 Aug; 7(8):. PubMed ID: 34431763
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Illumina and Oxford Nanopore Sequencing Technologies for Pathogen Detection from Clinical Matrices Using Molecular Inversion Probes.
Stefan CP; Hall AT; Graham AS; Minogue TD
J Mol Diagn; 2022 Apr; 24(4):395-405. PubMed ID: 35085783
[TBL] [Abstract][Full Text] [Related]
8. Subtyping Evaluation of
Xian Z; Li S; Mann DA; Huang Y; Xu F; Wu X; Tang S; Zhang G; Stevenson A; Ge C; Deng X
Appl Environ Microbiol; 2022 Aug; 88(15):e0078522. PubMed ID: 35867567
[TBL] [Abstract][Full Text] [Related]
9. The newest Oxford Nanopore R10.4.1 full-length 16S rRNA sequencing enables the accurate resolution of species-level microbial community profiling.
Zhang T; Li H; Ma S; Cao J; Liao H; Huang Q; Chen W
Appl Environ Microbiol; 2023 Oct; 89(10):e0060523. PubMed ID: 37800969
[TBL] [Abstract][Full Text] [Related]
10. Comparison of R9.4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction.
Sanderson ND; Kapel N; Rodger G; Webster H; Lipworth S; Street TL; Peto T; Crook D; Stoesser N
Microb Genom; 2023 Jan; 9(1):. PubMed ID: 36748454
[TBL] [Abstract][Full Text] [Related]
11. Do we still need Illumina sequencing data? Evaluating Oxford Nanopore Technologies R10.4.1 flow cells and the Rapid v14 library prep kit for Gram negative bacteria whole genome assemblies.
Lerminiaux N; Fakharuddin K; Mulvey MR; Mataseje L
Can J Microbiol; 2024 May; 70(5):178-189. PubMed ID: 38354391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of single-nucleotide variants identified by Illumina and Oxford Nanopore technologies in the context of a potential outbreak of Shiga toxin-producing Escherichia coli.
Greig DR; Jenkins C; Gharbia S; Dallman TJ
Gigascience; 2019 Aug; 8(8):. PubMed ID: 31433830
[TBL] [Abstract][Full Text] [Related]
13. Oxford nanopore sequencing in clinical microbiology and infection diagnostics.
Sheka D; Alabi N; Gordon PMK
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33483726
[TBL] [Abstract][Full Text] [Related]
14. Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry.
Dippenaar A; Costa Conceição E; Wells F; Loubser J; Mann B; De Diego Fuertes M; Rennie V; Warren RM; Van Rie A
PLoS One; 2024; 19(6):e0303938. PubMed ID: 38843147
[TBL] [Abstract][Full Text] [Related]
15. Application of Nanopore-Based Sequencing to Identify Virus Infections in Woody Plants.
Amoia SS; Chiumenti M; Minafra A
Methods Mol Biol; 2024; 2732():265-278. PubMed ID: 38060131
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants.
Riaz N; Leung P; Barton K; Smith MA; Carswell S; Bull R; Lloyd AR; Rodrigo C
BMC Genomics; 2021 Mar; 22(1):148. PubMed ID: 33653280
[TBL] [Abstract][Full Text] [Related]
17. An assessment of Oxford Nanopore sequencing for human gut metagenome profiling: A pilot study of head and neck cancer patients.
Wongsurawat T; Nakagawa M; Atiq O; Coleman HN; Jenjaroenpun P; Allred JI; Trammel A; Puengrang P; Ussery DW; Nookaew I
J Microbiol Methods; 2019 Nov; 166():105739. PubMed ID: 31626891
[TBL] [Abstract][Full Text] [Related]
18. Nanopore and Illumina sequencing reveal different viral populations from human gut samples.
Cook R; Telatin A; Hsieh SY; Newberry F; Tariq MA; Baker DJ; Carding SR; Adriaenssens EM
Microb Genom; 2024 Apr; 10(4):. PubMed ID: 38683195
[TBL] [Abstract][Full Text] [Related]
19. TARGETING THE 16S RRNA GENE FOR BACTERIAL IDENTIFICATION IN COMPLEX MIXED SAMPLES: COMPARATIVE EVALUATION OF SECOND (ILLUMINA) AND THIRD (OXFORD NANOPORE TECHNOLOGIES) GENERATION SEQUENCING TECHNOLOGIES.
Winand R; Bogaerts B; Hoffman S; Lefevre L; Delvoye M; Braekel JV; Fu Q; Roosens NH; Keersmaecker SC; Vanneste K
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906254
[TBL] [Abstract][Full Text] [Related]
20. Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.
Jabeen MF; Sanderson ND; Foster D; Crook DW; Cane JL; Borg C; Connolly C; Thulborn S; Pavord ID; Klenerman P; Street TL; Hinks TSC
Microbiol Spectr; 2022 Apr; 10(2):e0227921. PubMed ID: 35323032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
